June 23, 2022 -- Pictor has received Europe's CE Mark for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test.
The PictArray SARS-CoV-2 assay is the first test of its kind, according to the company. The test enables personalized COVID-19 assessments by detecting if a patient has antibodies from a previous infection of SARS-CoV-2 (from spike protein and nucleocapsid protein antibodies) or from vaccination alone (SP antibodies only).
In addition, the test also indicates whether at-risk patients have failed to mount a detectable antibody response, despite vaccination or infection (SP- and NP-negative), Pictor said.
The CE Mark allows the company to market its COVID-19 antibody test in Europe and seek regulatory approval in Southeast Asia.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current